Eflornithine difluoromethylornithine regulatory update

The COMP issued a positive opinion to grant Orphan Drug designation to Cancer Prevention's eflornithine to treat familial adenomatous polyposis. The ornithine decarboxylase inhibitor is in Phase II t...